3 results match your criteria: "Fundacion privada Hospital de Mollet[Affiliation]"
J Thromb Haemost
July 2015
Department of Internal Medicine, Hospital Universitari Germans Trias i Pujol, Universidad Católica de Murcia, Murcia, Spain.
Background: No studies have identified which patients with upper-extremity deep vein thrombosis (DVT) are at low risk for adverse events within the first week of therapy.
Methods: We used data from Registro Informatizado de la Enfermedad TromboEmbólica to explore in patients with upper-extremity DVT a prognostic score that correctly identified patients with lower limb DVT at low risk for pulmonary embolism, major bleeding, or death within the first week.
Results: As of December 2014, 1135 outpatients with upper-extremity DVT were recruited.
Nefrologia
November 2009
Servicio de Nefrología, Fundacion privada Hospital de Mollet, Barcelona.
Cephalic arch stenosis (CAS) is a unique type of vascular access stenosis. For example, the etiology of CAS is under investigation and the prevalence of CAS can be lower in diabetic patients. Three cases of CAS were identified during our vascular access stenosis surveillance program by blood flow rate measurements using the Delta-H method.
View Article and Find Full Text PDFNefrologia
January 2009
Servicio de Nefrología, Fundación Privada Hospital de Mollet, Barcelona.
Introduction: Periodic QA measurement is the preferred way for VA surveillance in end-stage renal disease (ESRD) patients (pts).
Objective: The aims of this study were to measure QA by TDT and to compare the functional results with Delta-H method.
Patients And Methods: We measured Q(A) non invasively in 38 VA (mean VA duration: 48.